News
MSD has gauged its financial hit from Trump tariffs
MSD expects to see an additional $200m layered onto its costs this year as a result of President Trump's tariffs, ahead of any pharma-specific levy.
Market Access
Partner Content
6th Gene Therapy Analytical Development Summit Europe
Join 24+ expert speakers and over 90 industry stakeholders to unlock analytical strategies that elevate your development programmes,...
News
Roche seeking talks with the US on tariff exemptions
Roche is petitioning the US administration for an exemption from tariffs for pharmaceuticals, arguing there is no trade imbalance in its US business.
News
Roche gets EU okay for chest pain algorithm
Roche has claimed a CE Mark in the EU for an AI algorithm that can help doctors decide whether patients with chest pain are having a heart attack.
News
First drug for rare disease APDS cleared for NHS use
Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat APDS, an ultra-rare immunodeficiency disorder.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
